Article
New generation live vaccines against human respiratory syncytial virus designed by reverse genetics.
Proceedings of the American Thoracic Society - 1 Jan 2005
Collins Peter L, Murphy Brian R
Abstract excerpt
Development of a live pediatric vaccine against human respiratory syncytial virus (RSV) is complicated by the need to immunize young infants and the difficulty in balancing attenuation and immunogenicity. The ability to introduce desired mutations into infectious virus by reverse genetics provides a method for identifying and designing highly defined attenuating mutations. These can be introduced in combinations...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
